Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration
Companies Extend Collaboration After Successful Preclinical Study Assessed the Quris-AI BioAI Drug Safety PlatformBOSTON and TEL AVIV, Israel, Sept. 28,...
Big Data
Neusoft Holds the Top Market Share of Medical Imaging Information System in China
SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022",...
Digital Biomarker Market Size to Grow USD 22360 Million by 2029 at a CAGR of 82.5% | Valuates Reports
BANGALORE, India, Sept. 14, 2023 /PRNewswire/ -- Digital Biomarker Market is Segmented by Type (Passive Digital Biomarker, Active Digital Biomarker),...
CalmWave Appoints Dr. Richard Schaefer, Chief Health Informatics Officer of the U.S. Department of Veterans Affairs, to Board of Advisors
Renowned Leader in Healthcare Technology Including AI Joins Esteemed Clinicians and ICU Physicians on Advisory BoardSEATTLE--(BUSINESS WIRE)--CalmWave, the company leveraging...
MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know...
Superluminal Medicines Launches with $33 Million Seed Round to Fuel its Drug Discovery Engine and Pipeline of Small Molecule Therapeutics
Financing led by RA Capital Management with participation from Insight Partners, NVIDIA, and Gaingels Superluminal combines deep biology and chemistry...
Wisconsin’s Pioneering Pathway Seeks to Secure Tech Hub Designation in Personalized Medicine
Madison, Wisconsin--(Newsfile Corp. - August 18, 2023) - Building on Wisconsin's statewide position of strength in personalized medicine, biohealth technology,...
Mindbio Therapeutics First Batch of MB22001 has Been Manufactured and is Ready for Use in World First Phase 2 Take at Home Psychedelic Clinical Trials
MB22001 has been manufactured ready for use in Phase 2 clinical trialsWorld first take-home approvals for psychedelic microdosingVANCOUVER, BC /...
Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success...
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
The Collaboration Signals Era of New Innovation for AI Nose Technology for Broader Industry AdoptionWith Partnership, Ainos Makes Progress Towards...
DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute
ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
REDWOOD CITY, CA / ACCESSWIRE / July 26, 2023 / The integration of AI technology in healthcare has revolutionized the...
Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google’s Tensor Flow for Remote Cardiac Care Applications
Company revolutionizes cardiac preventive care with state-of-the-art AI technology that improves automation, big data analytics and optimizationBiotricity expands its Amazon...
MindBio Therapeutics World First Phase 2 Take-Home LSD-Microdosing Clinical Trial in Patients with Major Depressive Disorder Begins Pre-Screening Participants
Patients meeting the selection criteria are currently being pre-screened for entry into the Phase 2 Depression trialEthics and clinical trials...
BioXcel Therapeutics Announces Positive Topline Results From TRANQUILITY II Phase 3 Trial of BXCL501 for Acute Treatment of Alzheimer’s Disease-Related Agitation
Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant 39% greater reduction in PEC...
After ChatGPT, Revolutionizing Healthcare with OMED AI: Unleashing the Power of Binance Blockchain
San Francisco, CA, April 14, 2023 (GLOBE NEWSWIRE) -- With the promise of revolutionary technologies and patient-centered care, OMED AI...
AAMI Releases Special Report on Artificial Intelligence
Arlington, VA, April 13, 2023 (GLOBE NEWSWIRE) -- If you’re wondering how artificial intelligence (AI) will affect your healthcare institution,...
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
Enable Cloud Platform trained on high plex spatial imaging datasets across 20,000 samples run on the PhenoCycler® SystemCommercial launch at...
Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples
BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay...
Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi
Abu Dhabi-based collaboration to focus on accelerating the development of new personalized medications using AIABU DHABI, United Arab Emirates, Jan....